When it may be considered
A balanced clinical framework.
Compounded GLP-1 Medications: A Patient Decision Guide
A balanced explanation of what compounded means, what it does not mean, what individual review requires, and how to compare a compounded option with an FDA-approved medication.
Short answer
Compounded semaglutide or tirzepatide may be considered only after individual physician review and when applicable conditions are met. They are not FDA-approved, are not brand-identical, and results vary.
Important: Compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical. Eligibility and results vary.
The rule is patient-specific, not automatic
Section 503A addresses preparations for identified patients with valid prescriptions. When a difference from a commercial product is relied on, a dose, concentration, or ingredient change does not automatically create an exception. The prescriber must determine and document that the change produces a significant difference for that patient.
What a compounded prescription does not prove
- It does not establish FDA approval or brand equivalence.
- It does not guarantee a dose, result, or individual response.
- It does not guarantee that a particular certificate or lot record is available.
- Cost alone does not replace a documented individual clinical need.
Practical questions for the pharmacy
Ask for the pharmacy name, what will appear on the label, storage instructions, the beyond-use date, and what product or lot documentation is available. Answers depend on the pharmacy, formulation, and lot and should be confirmed before fulfillment.
Compare every realistic option
If an FDA-approved medication is accessible, clinically appropriate, and affordable, it deserves a direct comparison. Coverage, supply, dosing format, tolerance, preferences, total cost, and follow-up can change the decision. A compounded option is not automatically better or worse.
B12 and lipotropic services are separate
B12/MIC is not included in the $199 trial. It may be offered separately when clinically appropriate, with formulation and pricing confirmed during consultation. Adding B12 does not by itself make a preparation legally distinct.
Published pricing
- Physician review: $119; medication is billed separately.
- Compounded semaglutide: $499 for 90 days, equivalent to $166 per month.
- Compounded tirzepatide: from $699 for 90 days, equivalent to $233 per month.
- One-month semaglutide trial: $199 with physician evaluation and, if the prescription is approved and a pharmacy can fulfill it for the patient's location, one month of medication. Packaging and shipping details are confirmed before fulfillment.
Pricing helps compare options; it is not a clinical or legal reason by itself. Eligibility, telehealth, and shipping depend on location and are confirmed during consultation.
Decision library
Compounded versus brand
Differences, limits, and alternatives.
503A versus 503B
An educational explanation.
Common questions
Pricing, eligibility, and follow-up.
Common questions
What is a compounded medication?
It is a preparation for an identified patient, made by a state-licensed compounding pharmacy operating under section 503A when there is a valid prescription and the physician determines and documents that applicable conditions are met.
Is it FDA-approved or brand-identical?
No. Compounded semaglutide and tirzepatide are not FDA-approved, are not brand-identical, and are not reviewed by the FDA for safety, effectiveness, or quality. Results vary.
Does changing a dose or adding B12 automatically make compounding permitted?
No. A dose, concentration, or ingredient change is not enough by itself. When the significant-difference exception is relied on, the prescriber must determine and document that difference for the identified patient.
What should I ask about the pharmacy?
Ask for the pharmacy name, what will appear on the label, storage instructions, the beyond-use date, and what product or lot documentation is available. Documentation varies by pharmacy and product.
Does the $199 trial include B12?
No. The trial includes physician evaluation and, if the prescription is approved and a pharmacy can fulfill it for the patient's location, one month of compounded semaglutide. Packaging and shipping details are confirmed before fulfillment. B12/MIC is not included and may be offered separately only when clinically appropriate.
Regulatory source: FDA guidance on sections 503A and 503B. Consult an official source or legal counsel for current interpretation.
This page is educational and is not individual medical or legal advice. Rules, supply, and availability can change. Compounded medications are not FDA-approved or brand-identical. Results vary.
Wegovy and Ozempic are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by those companies. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical. Results vary.